Found: 12
Select item for more details and to access through your institution.
Duchenne muscular dystrophy caused by a novel deep intronic DMD mutation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Brachium Pontis Stroke Revealing Neurofibromatosis Type-2.
- Published in:
- Journal of Neuroimaging, 2013, v. 23, n. 1, p. 132, doi. 10.1111/j.1552-6569.2011.00609.x
- By:
- Publication type:
- Article
Dual-energy X-ray absorptiometry measures of lean body mass as a biomarker for progression in boys with Duchenne muscular dystrophy.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-23072-5
- By:
- Publication type:
- Article
A homozygous CAP2 pathogenic variant in a neonate presenting with rapidly progressive cardiomyopathy and nemaline rods.
- Published in:
- American Journal of Medical Genetics. Part A, 2022, v. 188, n. 3, p. 970, doi. 10.1002/ajmg.a.62590
- By:
- Publication type:
- Article
Genotype-phenotype analysis of 4q deletion syndrome: Proposal of a critical region.
- Published in:
- American Journal of Medical Genetics. Part A, 2012, v. 158A, n. 9, p. 2139, doi. 10.1002/ajmg.a.35502
- By:
- Publication type:
- Article
Clinical Follow-Up for Duchenne Muscular Dystrophy Newborn Screening: A Proposal.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Twenty-year follow-up of newborn screening for patients with muscular dystrophy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Parental attitudes toward newborn screening for Duchenne/Becker muscular dystrophy and spinal muscular atrophy.
- Published in:
- Muscle & Nerve, 2014, v. 49, n. 6, p. 822, doi. 10.1002/mus.24100
- By:
- Publication type:
- Article
Medical management of muscle weakness in Duchenne muscular dystrophy.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0240687
- By:
- Publication type:
- Article
A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen Treatment.
- Published in:
- Journal of Neuromuscular Diseases, 2022, v. 9, n. 1, p. 39, doi. 10.3233/JND-210665
- By:
- Publication type:
- Article
Open-Label Evaluation of Eteplirsen in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping: PROMOVI Trial.
- Published in:
- Journal of Neuromuscular Diseases, 2021, v. 8, n. 6, p. 989, doi. 10.3233/JND-210643
- By:
- Publication type:
- Article
Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 8, p. 4421, doi. 10.1007/s00415-022-11084-0
- By:
- Publication type:
- Article